Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Market Cap	1.13T
Revenue (ttm)	397.55B
Net Income (ttm)	127.36B
Shares Out	21.50M
EPS (ttm)	5,923.94
PE Ratio	8.86
Forward PE	7.91
Dividend	3,000.00 (5.71%)
Ex-Dividend Date	Mar 21, 2025

Volume	1,200
Average Volume	12,273
Open	52,500
Previous Close	52,500
Day's Range	52,500 - 52,700
52-Week Range	47,700 - 65,000
Beta	0.32
RSI	37.00
Earnings Date	Jul 21, 2025

About Theseus Pharmaceuticals

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2024, HNX:DP3's revenue was 417.49 billion, an increase of 1.89% compared to the previous year's 409.73 billion. Earnings were 121.17 billion, a decrease of -3.27%.